These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8366296)

  • 1. Clinical significance of the new tumor marker MCA in the follow-up of patients with mammary carcinoma.
    Müller-Brand J; Mäcke H
    Int J Biol Markers; 1993; 8(2):130-2. PubMed ID: 8366296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic value of mucinous carcinoma-associated antigen (MCA) tests in breast carcinomas.
    Günes I; Miserez AR; Müller-Brand J; Maecke H
    Int J Biol Markers; 1992; 7(4):222-4. PubMed ID: 1491177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucin-like carcinoma-associated antigen (MCA) in breast cancer: clinical experience at the National Cancer Institute of Milan.
    Seregni E; Crippa F; Botti C; Bellotti MG; Bogni A; Pizzichetta M; Bombardieri E
    Int J Biol Markers; 1993; 8(2):124-9. PubMed ID: 8366295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucin-like carcinoma-associated antigen (MCA) in tissue and serum of patients with breast cancer: clinical applications in prognosis and disease monitoring.
    Molina R; Jo J; Filella X; Zanon G; Grau JJ; Joseph J; Bedini JL; Biete A; Ballesta AM
    Int J Biol Markers; 1993; 8(2):113-23. PubMed ID: 8366294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic value of mucin-like associated antigen (MCA) in neoplasms of the mammary gland].
    Kopczyński Z; Stachowicz A; Kociałkowski K; Grodecka-Gazdecka S
    Ginekol Pol; 1993 Feb; 64(2):87-92. PubMed ID: 8359732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucin-like carcinoma associated antigen (MCA) at presentation with breast cancer.
    Horgan PG; Byrne J; O'Donoghue J; Mooney E; Grimes H; Given HF
    Ir J Med Sci; 1997; 166(4):215-6. PubMed ID: 9394068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid, automated enzyme immunoassay for MCA with the Cobas Core Roche immunochemistry analyser.
    Henne V; Maurer A
    Int J Biol Markers; 1993; 8(2):133-7. PubMed ID: 8366297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of a mucin-like carcinoma-associated antigen in monitoring breast cancer patients in comparison with CA 15-3.
    Miserez AR; Günes I; Müller-Brand J; Walther E; Fridrich R; Mäcke H
    Eur J Cancer; 1991; 27(2):126-31. PubMed ID: 1827273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucin-like cancer-associated antigen (MCA) compared with CA 15-3 in advanced breast cancer.
    Steger GG; Mader R; Derfler K; Moser K; Dittrich C
    Klin Wochenschr; 1989 Aug; 67(16):813-7. PubMed ID: 2796251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of mucin-like carcinoma-associated antigen (MCA) in breast cancer.
    Rasoul-Rockenschaub S; Zielinski CC; Kubista E; Vavra N; Pospischil E; Staffen A; Czerwenka K; Aiginger P; Spona J
    Eur J Cancer Clin Oncol; 1989 Jul; 25(7):1067-72. PubMed ID: 2759162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MCA serum determination in breast carcinoma patients for the diagnosis of bone metastases.
    Dominguez-Gadea L; Martin-Curto LM; Crespo A; Avila C
    Int J Biol Markers; 1993; 8(4):203-7. PubMed ID: 8138659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum concentrations of the MCA tumor marker during pregnancy].
    Pütz I; Lang G; Winkler M; Rath W
    Zentralbl Gynakol; 1996; 118(7):409-11. PubMed ID: 8766103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple method for comparing reliability of two serum tumour markers in breast carcinoma.
    O'Brien DP; Gough DB; Skehill R; Grimes H; Given HF
    J Clin Pathol; 1994 Feb; 47(2):134-7. PubMed ID: 8132827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of mucinous carcinoma associated antigen (MCA) levels in patients with breast cancer.
    Migali E; Ozzola G; Mariotti D; Ghezzi P; Rinaldini M; Magnanini S
    Int J Biol Markers; 1992; 7(1):61-4. PubMed ID: 1583350
    [No Abstract]   [Full Text] [Related]  

  • 15. MCA performance in preoperative breast cancer patients.
    Donadeo A; Micelli G; Quaranta M; Atlante A; Schittulli F
    Anticancer Res; 1995; 15(2):527-9. PubMed ID: 7763034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary study on serum levels of mucinous like cancer antigen (MCA) in patients with breast disease: comparison with CEA.
    Boccardo F; Bombardieri E; Zanardi S; Valenti G; Zanaboni F; Valtolina M; Seregni E; Crippa F
    Int J Biol Markers; 1991; 6(1):12-20. PubMed ID: 1856512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of CA 15-3, mucin-like carcinoma-associated antigen, tumor polypeptide antigen, and carcinoembryonic antigen in monitoring early breast cancer patients.
    Pectasides D; Pavlidis N; Gogou L; Antoniou F; Nicolaides C; Tsikalakis D
    Am J Clin Oncol; 1996 Oct; 19(5):459-64. PubMed ID: 8823487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of tissue polypeptide specific antigen TPS determination in serum of women with breast cancer comparison to mucin-like associated antigen MCA and CA 15-3 antigen.
    Kopczyński Z; Thielemann A
    Eur J Gynaecol Oncol; 1998; 19(5):503-7. PubMed ID: 9863926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum MCA, CA 125 and CA 19.9 determination in primary breast cancer.
    Yenisey C; Güner G
    Biochem Soc Trans; 1996 May; 24(2):302S. PubMed ID: 8736960
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical evaluation of potential usefulness of CEA, CA 15-3, and MCA in follow-up of breast cancer patients.
    Jezersek B; Cervek J; Rudolf Z; Novaković S
    Cancer Lett; 1996 Dec; 110(1-2):137-44. PubMed ID: 9018092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.